Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

Similar articles for PubMed (Select 22664917)

1.

MicroRNAs, wild-type and mutant p53: more questions than answers.

Jones M, Lal A.

RNA Biol. 2012 Jun;9(6):781-91. doi: 10.4161/rna.20146. Epub 2012 Jun 1. Review.

2.

Tumor suppressor p53 meets microRNAs.

Feng Z, Zhang C, Wu R, Hu W.

J Mol Cell Biol. 2011 Feb;3(1):44-50. doi: 10.1093/jmcb/mjq040. Review.

3.

Dynamics of microRNA biogenesis: crosstalk between p53 network and microRNA processing pathway.

Suzuki HI, Miyazono K.

J Mol Med (Berl). 2010 Nov;88(11):1085-94. doi: 10.1007/s00109-010-0650-1. Epub 2010 Jul 8. Review.

PMID:
20614100
4.

Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer.

Xi Y, Shalgi R, Fodstad O, Pilpel Y, Ju J.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2014-24.

5.

Modulation of microRNA processing by p53.

Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K.

Nature. 2009 Jul 23;460(7254):529-33. doi: 10.1038/nature08199.

PMID:
19626115
6.

Helpers of the cellular gatekeeper-miRNAs dance in P53 network.

Shi M, Liu D, Shen B, Guo N.

Biochim Biophys Acta. 2010 Apr;1805(2):218-25. doi: 10.1016/j.bbcan.2009.12.001. Epub 2009 Dec 16. Review.

PMID:
20006673
7.

p53 mutations in cancer.

Muller PA, Vousden KH.

Nat Cell Biol. 2013 Jan;15(1):2-8. doi: 10.1038/ncb2641. Review.

PMID:
23263379
8.

Mutant p53 exerts oncogenic effects through microRNAs and their target gene networks.

Li XL, Jones MF, Subramanian M, Lal A.

FEBS Lett. 2014 Aug 19;588(16):2610-5. doi: 10.1016/j.febslet.2014.03.054. Epub 2014 Apr 12. Review.

PMID:
24726728
9.

The impact of post-transcriptional regulation in the p53 network.

Freeman JA, Espinosa JM.

Brief Funct Genomics. 2013 Jan;12(1):46-57. doi: 10.1093/bfgp/els058. Epub 2012 Dec 14. Review.

10.

Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest.

Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A, Meister G, Hermeking H.

Cell Cycle. 2007 Jul 1;6(13):1586-93. Epub 2007 May 11.

11.

The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex.

Boominathan L.

PLoS One. 2010 May 12;5(5):e10615. doi: 10.1371/journal.pone.0010615.

12.

p53 enters the microRNA world.

Hermeking H.

Cancer Cell. 2007 Nov;12(5):414-8. Review.

13.

Tiny actors, great roles: microRNAs in p53's service.

Raver-Shapira N, Oren M.

Cell Cycle. 2007 Nov 1;6(21):2656-61. Epub 2007 Aug 19. Review.

14.

MicroRNAs that respond to histone deacetylase inhibitor SAHA and p53 in HCT116 human colon carcinoma cells.

Shin S, Lee EM, Cha HJ, Bae S, Jung JH, Lee SM, Yoon Y, Lee H, Kim S, Kim H, Lee SJ, Park IC, Jin YW, An S.

Int J Oncol. 2009 Dec;35(6):1343-52.

PMID:
19885557
15.

p53-Repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation.

Brosh R, Shalgi R, Liran A, Landan G, Korotayev K, Nguyen GH, Enerly E, Johnsen H, Buganim Y, Solomon H, Goldstein I, Madar S, Goldfinger N, Børresen-Dale AL, Ginsberg D, Harris CC, Pilpel Y, Oren M, Rotter V.

Mol Syst Biol. 2008;4:229. doi: 10.1038/msb.2008.65. Epub 2008 Nov 25.

16.

The p53/microRNA network in cancer: experimental and bioinformatics approaches.

Hünten S, Siemens H, Kaller M, Hermeking H.

Adv Exp Med Biol. 2013;774:77-101. doi: 10.1007/978-94-007-5590-1_5. Review.

PMID:
23377969
17.

miRNA response to DNA damage.

Wan G, Mathur R, Hu X, Zhang X, Lu X.

Trends Biochem Sci. 2011 Sep;36(9):478-84. doi: 10.1016/j.tibs.2011.06.002. Epub 2011 Jul 7. Review.

18.

miRNA expression profiling of the murine TH-MYCN neuroblastoma model reveals similarities with human tumors and identifies novel candidate miRNAs.

Terrile M, Bryan K, Vaughan L, Hallsworth A, Webber H, Chesler L, Stallings RL.

PLoS One. 2011;6(12):e28356. doi: 10.1371/journal.pone.0028356. Epub 2011 Dec 2.

19.

Promyelocytic leukemia protein is required for gain of function by mutant p53.

Haupt S, di Agostino S, Mizrahi I, Alsheich-Bartok O, Voorhoeve M, Damalas A, Blandino G, Haupt Y.

Cancer Res. 2009 Jun 1;69(11):4818-26. doi: 10.1158/0008-5472.CAN-08-4010.

20.

The p53 miRNA interactome and its potential role in the cancer clinic.

Krell J, Frampton AE, Colombo T, Gall TM, De Giorgio A, Harding V, Stebbing J, Castellano L.

Epigenomics. 2013 Aug;5(4):417-28. doi: 10.2217/epi.13.41. Review.

PMID:
23895654
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk